Cholinergic Modulation of Type 2 Immune Responses

In recent years, the bidirectional relationship between the nervous and immune system has become increasingly clear, and its role in both homeostasis and inflammation has been well documented over the years. Since the introduction of the cholinergic anti-inflammatory pathway, there has been an incre...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology Vol. 8; p. 1873
Main Authors: Bosmans, Goele, Shimizu Bassi, Gabriel, Florens, Morgane, Gonzalez-Dominguez, Erika, Matteoli, Gianluca, Boeckxstaens, Guy E
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 19-12-2017
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In recent years, the bidirectional relationship between the nervous and immune system has become increasingly clear, and its role in both homeostasis and inflammation has been well documented over the years. Since the introduction of the cholinergic anti-inflammatory pathway, there has been an increased interest in parasympathetic regulation of both innate and adaptive immune responses, including T helper 2 responses. Increasing evidence has been emerging suggesting a role for the parasympathetic nervous system in the pathophysiology of allergic diseases, including allergic rhinitis, asthma, food allergy, and atopic dermatitis. In this review, we will highlight the role of cholinergic modulation by both nicotinic and muscarinic receptors in several key aspects of the allergic inflammatory response, including barrier function, innate and adaptive immune responses, and effector cells responses. A better understanding of these cholinergic processes mediating key aspects of type 2 immune disorders might lead to novel therapeutic approaches to treat allergic diseases.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
Edited by: Valentin A. Pavlov, Northwell Health, United States
Reviewed by: Maryna Skok, Palladin Institute of Biochemistry (NAS Ukraine), Ukraine; Regina Pekelmann Markus, University of São Paulo, Brazil
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2017.01873